Albany Medical College
Tranexamic acid (TXA) is an agent that has been shown to be safe and effective to reduce blood loss in surgical procedures. The purpose of the study is to assess the effect of transexamic on elective decompressive lumbar spine surgery with and without fusion.
This will be a prospective randomized control, double-blinded investigation. The Investigators will recruit patients undergoing elective, primary, decompressive lumbar surgery via a posterior surgical approach of less than 3 levels. This includes patients undergoing decompressive lumbar laminectomies with or without fusion. Fusion may include posterior interbody and/or posterior lateral techniques with instrumentation. There will be 3 treatment arms with the goal of 65 patients in each arm. Patients will be randomized pre-operatively and enrolled into the IV transexamic acid group (receiving…
Inclusion Criteria: * Patients undergoing decompressive lumbar laminectomy with or without fusion * Primary surgical procedure * Competent adult able to give informed consent * Age \>18 Exclusion Criteria: * h/o DVT or PE * h/o seizure * h/o coagulopathy * Diagnosis of malignancy or infection as indication for surgical decompression * Abnormal pre-operative PT/INR, aPTT, bleeding time * Platelet count \< 100 * Patients requiring therapeutic heparin or lovenox bridges prior to and/or after surgery * Allergy to TXA * Pregnant women and prisoners * Renal insufficiency
IV and topical form of TXA will be administered to patients in the respective groups.
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.